Type I interferon signaling induces melanoma cell-intrinsic PD-1 and its inhibition antagonizes immune checkpoint blockade.
Nature communications
View this publicationNature communications
View this publicationCritical care medicine
View this publicationInternational journal of molecular sciences
View this publicationCritical care medicine
View this publicationAnnals of clinical and translational neurology
View this publicationBMC nephrology
View this publicationCell reports
View this publicationAnnals of neurology
View this publicationNucleic acids research
View this publicationRheumatology international
View this publication